Cargando…
Remission-Stage Ovarian Cancer Cell Vaccine with Cowpea Mosaic Virus Adjuvant Prevents Tumor Growth
SIMPLE SUMMARY: Ovarian cancer survival rates are poor, with most deaths occurring from cancer recurrence following initial remission. Accordingly, there is a significant need for treatments that prevent relapse. Here, using a therapeutic vaccine against a mouse model of ovarian cancer, we evaluate...
Autores principales: | Stump, Courtney T., Ho, Gregory, Mao, Chenkai, Veliz, Frank A., Beiss, Veronique, Fields, Jennifer, Steinmetz, Nicole F., Fiering, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915664/ https://www.ncbi.nlm.nih.gov/pubmed/33562450 http://dx.doi.org/10.3390/cancers13040627 |
Ejemplares similares
-
In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade
por: Mao, Chenkai, et al.
Publicado: (2022) -
Cowpea Mosaic Virus Nanoparticle Enhancement of Hypofractionated Radiation in a B16 Murine Melanoma Model
por: Duval, Kayla E. A., et al.
Publicado: (2020) -
In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer
por: Lizotte, P. H., et al.
Publicado: (2015) -
Transcriptomics of Canine Inflammatory Mammary Cancer Treated with Empty Cowpea Mosaic Virus Implicates Neutrophils in Anti-Tumor Immunity
por: Barreno, Lucia, et al.
Publicado: (2023) -
Slow‐Release Formulation of Cowpea Mosaic Virus for In Situ Vaccine Delivery to Treat Ovarian Cancer
por: Czapar, Anna E., et al.
Publicado: (2018)